Cephalon Stays Focused On Provigil; ADHD Launch Will Boost Sales Force 40%
Executive Summary
Cephalon expects to increase its sales force by 40% in the second half of 2005 in order to support an upcoming launch of Provigil (modafinil) for pediatric attention deficit hyperactivity disorder